CD4 and immunodeficiency disease: During the initiation of ART, 59 (24.0%) of study participant were found to be in advanced immunodeficiency state with CD4 <200 cells/mm3 and of these, 8 (3.3%) were at severe immunological stage with CD4 count <50 cells/mm3.